Indemnity, clinical governance, training, planning, and implementation issues were addressed. The outcome measures were patient safety, patient experience, and clinic capacity. Anti-vascular ...
Two European firms team up to lead RepliCel's next-generation dermal injector (RCI-02) to market-ready status VANCOUVER, Feb. 28, 2017 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB:REPCF) (TSXV:RP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback